|Bid||33.560 x 8600|
|Ask||33.570 x 9800|
|Day's Range||33.335 - 33.700|
|52 Week Range||29.830 - 37.390|
|PE Ratio (TTM)||28.28|
|Dividend & Yield||1.28 (3.84%)|
|1y Target Est||N/A|
In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000.
Analysts downgrade PFE as they suggest that the big pharma stock has limited drivers of upside.
Previewing second-quarter results of Pfizer Inc. (NYSE: PFE ), Credit Suisse prescribed a Neutral rating for the shares of the company, down from its previous Outperform rating. Pfizer is scheduled to ...